Convergent QSAR studies on a series of NK₃ receptor antagonists for schizophrenia treatment

References

• WHO, World Health Organization. Mental Health: schizophrenia. Available from: http://www.who.int/mental_health/management/schizophrenia/en/ [last accessed 13 Jun 2013]
   Google Scholar
• Lisman J. Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr Opin Neurobiol 2011;22:1–8
   Google Scholar
• Spooren W, Riemer C, Meltzer H. NK3 receptor antagonists: the next generation of antipsychotics? Nat Rev Drug Discov 2005;4:967–75
   PubMed Web of Science ®Google Scholar
• Juhl K, Hansen T, Kehler J, et al. Identification of a new series of non-peptidic NK3 receptor antagonists. Bioorg Med Chem 2011;21:1498–501
   Web of Science ®Google Scholar
• Hoveyda HR, Roy MO, Blanc S, et al. Discovery of 3-aryl-5-acylpiperazinyl pyrazoles as antagonists to the NK3 receptor. Bioorg Med Chem 2011;21:1991–6
   Web of Science ®Google Scholar
• Malherbe P, Knoflach F, Marcuz A, et al. Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: biochemical and electrophysiological characterization. Neuropharmacology 2014;86:259–72
   PubMed Web of Science ®Google Scholar
• Hanessian S, Jennequin T, Boyer N, et al. Design, synthesis, and optimization of balanced dual NK1/NK3 receptor antagonists. Med Chem Lett 2014;5:550–5
   Web of Science ®Google Scholar
• Arroio A, Honório KM, Silva ABF. Propriedades químico-quânticas empregadas em estudos das relações estrutura-atividade. Quím Nova 2010;33:694–9
   Web of Science ®Google Scholar
• Kiralj R, Ferreira MMC. Basic validation procedures for regression models in QSAR and QSPR studies: theory and applications. J Braz Chem Soc 2009;20:770–87
   Web of Science ®Google Scholar
• Oprea TI. On the information content of 2D and 3D descriptors for QSAR. Braz Chem Soc 2002;13:811–5
   Web of Science ®Google Scholar
• Gertrudes JC, Maltarollo VG, Silva RA, et al. Machine learning techniques and drug design. Curr Med Chem 2012;19:4289–97
   PubMed Web of Science ®Google Scholar
• Cherkasov A, Muratov EN, Fourches D, et al. QSAR modeling: where have you been? Where are you going to? J Med Chem 2014;57:4977–5010
   PubMed Web of Science ®Google Scholar
• Nagar S, Saha A. Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer. J Comput Chem 2010;31:2342–53
   PubMed Web of Science ®Google Scholar
• Agarwal A, Taylor EW. 3-D QSAR for intrinsic activity of 5-HT1A receptor ligands by the method of comparative molecular field analysis. J Comput Chem 2004;14:237–45
   Google Scholar
• Geldenhuysa WJ, Simmons MA. 3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor. Bioorg Med Chem Lett 2011;21:7405–11
   PubMed Web of Science ®Google Scholar
• Geldenhuys WJ, Kuzenko SR, Simmons MA. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor. J Med Chem 2010;53:8080–8
   PubMed Web of Science ®Google Scholar
• ChemAxon. (2012) Marvin Sketch 5.10.13 ed
   Google Scholar
• Hawkins PCD, Skillman AG, Warren GL, et al. Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inf Model 2010;50:572–84
   PubMed Web of Science ®Google Scholar
• OpenEye Scientific Software (2013) OMEGA 2.5.1.4 edn. Available from: http://www.eyesopen.com
   Google Scholar
• Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 1996;17:490–519
   Web of Science ®Google Scholar
• Hawkins PCD, Skillman AG, Nicholls A. Comparison of shape-matching and docking as virtual screening tools. J Med Chem 2007;50:74–82
   PubMed Web of Science ®Google Scholar
• OpenEye Scientific Software (2013) ROCS 3.2.0.4 edn. Available from: http://www.eyesopen.com
   Google Scholar
• Stewart JJP. Optimization of parameters for semiempirical methods I. Method J Comput Chem 1989;10:209–20
   Web of Science ®Google Scholar
• Stewart JJP. Optimization of parameters for semiempirical methods II. Applications. J Comput Chem 1989;10:221–64
   Web of Science ®Google Scholar
• Tripos Inc. (2013) Sybyl-X Suite 2.1.1 edn
   Google Scholar
• Fock V. Năherungsmethode zur Lasung des quantenmechanischen Mehrkarperpro-blems. Z Phys 1930;61:126–48
   Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. (2004) Gaussian 03, Revision C.02
   Google Scholar
• Infometrix Inc. (2003) Pirouette 3.11 edn
   Google Scholar
• Beebe KR, Pell RJ, Seasholtz MB. Chemometrics: a practical Guide; 1998
   Google Scholar
• Ferreira MMC. Multivariate QSAR. J Braz Chem Soc 2002;13:742–53
   Web of Science ®Google Scholar
• Schuurmann G, Ebert RU, Chen J, et al. External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs training set activity mean. J Chem Inf Model 2008;48:2140–5
   PubMed Web of Science ®Google Scholar
• Golbraikh A, Tropsha A. Beware of q2!. J Mol Graph Model 2002;20:269–76
   PubMed Web of Science ®Google Scholar
• Guido RVC, Trossini GHG, Castilho MS, et al. Structure–activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi. J Enzyme Inhib Med Chem 2008;23:964–73
   PubMed Web of Science ®Google Scholar
• Carvalho LL, Maltarollo VG, Lima EF, et al. Molecular features related to HIV integrase inhibition obtained from structure-and ligand-based approaches. PLoS One 2014;9:1–9
   Web of Science ®Google Scholar
• Araujo SC, Maltarollo VG, Honório KM. Computational studies of TGF-βRI (ALK-5) inhibitors: analysis of the binding interactions between ligand-receptor using 2D and 3D techniques. Eur J Pharm Sci 2013;49:542–9
   PubMed Web of Science ®Google Scholar
• Maltarollo VG, Silva DC, Honório KM. Advanced QSAR studies on PPARδ ligands related to metabolic diseases. J Braz Chem Soc 2012;23:78–84
   Google Scholar
• Cunha LB, Freitas HF, Castilho MS. Hologram-and descriptor-based QSAR studies for a series of non-azoles derivatives active against C. neoformans. J Braz Chem Soc 2013;24:1623–34
   Web of Science ®Google Scholar
• Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V. Advances in computational methods to predict the biological activity of compounds. Expert Opin Drug Discov 2010;5:633–54
   PubMed Web of Science ®Google Scholar
• Lowis DR. HQSAR: a new, highly Predictive QSAR Technique; 1997
   Google Scholar
• Clark M, Cramer III RD, Opdenbosch NV. Validation of the general purpose Tripos 5.2 forcefield. J Comput Chem 1989;10:982–1012
   Web of Science ®Google Scholar
• Andricopulo AD, Salum LB. Fragment-based QSAR: perspectives in drug design. Mol Divers 2009;13:277–85
   PubMed Web of Science ®Google Scholar
• Meylan WM, Howard PH. Estimating log P whit atom/fragments and water solubility with log P. Perspect Drug Discov Des 2000;19:67–84
   Web of Science ®Google Scholar
• Craig PM. Interdependence between physical parameters and selection of substituent groups for correlation studies. J Med Chem 1071;14:680–4
   Google Scholar